China Launches Major Public Health Initiatives to Enhance Healthcare Accessibility
In a bid to bolster public health infrastructure and improve healthcare services, China’s National Health...
Sanofi and J&J’s E. coli Vaccine Fails Phase III Study
France-based Sanofi (NASDAQ: SNY) and US giant Johnson & Johnson’s (J&J, NYSE: JNJ) vaccine candidate...
Antengene’s Xpovio Included in Taiwan’s NHI Drug List for Myeloma Treatment
China-based biopharma Antengene Corp., Ltd (HKG: 6996) announced that its Xpovio (selinexor), the world’s first...
Boehringer Ingelheim Partners with ExpressionEdits on Gene Therapy Tech
German pharmaceutical giant Boehringer Ingelheim has entered into a collaboration and licensing agreement with UK-based...
Merck’s Zerbaxa Approved by China’s NMPA for Complex Infections
US-based pharmaceutical giant Merck, Sharp & Dohme Inc. (MSD, NYSE: MRK) announced that it has...
Hainan Unveils Biomedical New Technology Policy to Boost Medical Innovation
In-Depth Analysis and Orientation Guide for Hainan’s Biomedical New Technology PolicyThe Hainan Provincial Health Commission,...
Roche’s Evrysdi Tablet Approved by FDA for Spinal Muscular Atrophy
Swiss giant Roche (SWX: ROG) has announced that it has received marketing approval from the...
Shanghai’s Ambitious Plan to Revolutionize Brain-Computer Interfaces
In-Depth Analysis and Orientation Guide for Shanghai’s Brain-Computer Interface (BCI) PolicyShanghai has unveiled a groundbreaking...
Pfizer’s Adcetris Gets New FDA Approval for Lymphoma Treatment
US giant Pfizer (NYSE: PFE) has announced that it has received another indication approval from...
StairMed Raises Record RMB350m for Implantable BCI Development
Shanghai StairMed Technology Co., Ltd., a specialist in implantable brain-computer interface (BCI) technology, has reportedly...
Lundbeck’s Amlenetug Receives FDA Fast Track for Multiple System Atrophy
Denmark-based pharma company Lundbeck A/S (VIE: LUNB) has announced that it has received Fast Track...
OnCusp Therapeutics’ CUSP06 Receives FDA Fast Track for Ovarian Cancer
Sino-US company OnCusp Therapeutics Inc. has announced that it has received Fast Track Designation (FTD)...
J&J Considers Selling Stroke Care Business Cerenovus for USD1-1.5 Billion
US giant Johnson & Johnson (J&J, NYSE: JNJ) is reportedly considering selling its stroke care...
Anhui Anke to Invest in Visen Pharma’s Hong Kong IPO as Cornerstone Investor
China – based Anhui Anke Biotechnology (Group) Co., Ltd (SHE: 300009) has announced its plan...
Boao Airport Customs Releases First Batch of Modulen IBD for Crohn’s Disease Management
The Boao Airport Customs under Haikou Customs has released the first batch of 96 pieces...
AbbVie Collaborates with Xilio Therapeutics on Tumor-Activated Immunotherapies
US pharmaceutical giant AbbVie (NYSE: ABBV) has announced a collaboration and option-to-license agreement with fellow...
Astellas Pharma’s Izervay Gets FDA Approval for GA Treatment Without Dosing Limit
Japan-based Astellas Pharma Inc. (TYO: 4503) has announced that the US Food and Drug Administration...
Andon Health to Fully Control iHealth by Acquiring Best Ventures’ Stake
China-based Andon Health Co., Ltd (SHE: 002432) announced a plan to obtain the 20% stake...
Hengrui Pharma’s BD Head Dr. Chen Dong Departs for AbbVie’s External Innovation Role
Dr. Chen Dong, Vice President and China Head of BD at Jiangsu Hengrui Pharmaceuticals Co.,...
Huadong Medicine’s Biosimilar SaiYueXin Seeks NMPA Approval for Crohn’s Disease
Huadong Medicine Co., Ltd (SHE: 000963) announced that another indication approval filing for its SaiYueXin,...